Serbest (1) 30 ml bakteriyostatik su
Nitelikli siparişlerle500 $ USD.
(Kapsül ürünleri, kozmetik peptitler, promosyon kodları ve nakliye hariç)
GHK-CIinsan kan plazması, idrar ve tükürükte doğal bir peptittir. Hayvanlarda yapılan araştırmalar, GHK-CU'nun kollajen, fibroblastları uyararak ve kan damarı büyümesini teşvik ederek yara iyileşmesini, bağışıklık fonksiyonunu ve cilt sağlığını iyileştirebileceğini ortaya koymaktadır. Doku hasarından sonra üretilen bir geri bildirim sinyali olarak hareket ettiğini gösteren kanıtlar olmuştur. Ayrıca serbest radikal hasarı baskılar ve bu nedenle güçlü bir antioksidandır.
Ürün Kullanımı:Bu ürün sadece bir araştırma kimyasal olarak tasarlanmıştır.Bu atama, sadece in vitro test ve laboratuvar deneyleri için araştırma kimyasallarının kullanılmasına izin verir. Bu web sitesinde bulunan tüm ürün bilgileri yalnızca eğitim amaçlıdır. İnsanlara veya hayvanlara her türlü bedensel olarak tanıtılması, yasalarca kesinlikle yasaktır. Bu ürün sadece lisanslı, nitelikli profesyoneller tarafından ele alınmalıdır. Bu ürün bir ilaç, gıda veya kozmetik değildir ve bir ilaç, yiyecek veya kozmetik olarak yanlış markalanmış, yanlış kullanılmaz veya yanlış tablo verilmeyebilir.
GHK-CU, önce insan kan plazmasından izole edilen doğal olarak oluşan bir peptittir. O zamandan beri idrar ve tükürükte de tanımlanmıştır. GHK-CU ile ilgili araştırmalar, kısa peptidi yara iyileşme ve bağışıklık fonksiyonunda önemli faydalar sağladığını bulmuştur. Yaşlanma karşıtı özelliklere sahiptir ve serbest radikal hasarını baskıladığı, protein sentezini arttırdığı, bakterilerle savaştığı ve cilt ve cilt fibroblastlarının sağlığını arttırdığı bulunmuştur.
Sekans:Gly-his-lys.cu.xhac
Moleküler Formül:C14H23CUN6O4
Moleküler ağırlık:340.384 g/mol
Pubchem CID: 73587
CAS Numarası:89030-95-5
GHK-CU, insan kanının doğal bir parçasıdır ve bu nedenle cilt rejenerasyon yollarında ayrılmaz bir rol oynadığı bulunmuştur. Cilt kültürlerinde yapılan araştırmalar, GHK'nın kollajen, glikozaminoglikanların ve proteoglikanlar ve kondroitin sülfat gibi diğer hücre dışı matris bileşenlerinin sentezini ve bozulmasını uyardığını bulmuştur. Bu etkinin en azından bir kısmına GHK-CU'nun fibroblastlar, bağışıklık hücreleri ve endotel hücreleri üzerindeki pozitif işe alım faydaları aracılığıyla aracılık edilir. Peptit, bu hücreleri yaralanma bölgesine çeker ve hasarı onarmada aktivitelerini koordine ettiği görülür.[1].
GHK-Cu is a common component of skin-care and cosmetic products. It improves elasticity of the skin while tightening and firming. It has also been shown to reduce damage due to sunlight, reduce hyperpigmentation, and reduce the appearance of fine lines and wrinkles[1]. The ability of GHK-Cu to modulate collagen synthesis is important in reducing the appearance of scars, preventing hypertrophic healing from taking place, smoothing rough skin, and repair the structure of aged skin. These roles of GHK-Cu are mediated partly though its ability to boost levels of transforming growth factor-Β[2]. It is likely that the peptide works through several different biochemical pathways and that it has effects and the level of gene transcription[3].
Research in mice shows that GHK-Cu increases the rate of healing following burn by as much as 33%. It appears that besides recruiting immune cells and fibroblasts to the site of injury, GHK-Cu also encourages the growth of blood vessels[4]. Burned skin is often slow to regrow blood vessels due the cauterization effect, so these findings open up a new pathway for improving wound care in burn units and accelerating healing.
The invasion of tissue by foreign pathogens is one of the primary reasons that wounds are slow to heal or do not heal at all. Bacterial and fungal infections are particularly problematic in burn patients and in those with compromised immune systems (e.g. diabetes, HIV). GHK-Cu, when combined with certain fatty acids, creates a potent antimicrobial compound that is active against a number of bacteria and fungi known to complicate wound healing[5].
Research in diabetic patients has shown that GHK-Cu is superior to standard care regimens alone in the treatment of diabetic ulcers. Patients given both standard care and GHK-Cu showed a ~40% increase in wound closure and a 27% decrease in rates of infection compared to control groups[6]. Similar results were seen in patients with ischemic open wounds[7].
The death of neurons due to degenerative diseases like Alzheimer’s is poorly understood. This makes it difficult to develop treatments and those that are available are generally of limited efficacy. Research, however, suggests that GHK-Cu can counter the age-associated decline in neuron function that often underlies these diseases. Research shows that GHK-Cu can improve angiogenesis in the nervous system, boost nerve outgrowth, and reduce inflammation in the central nervous system. There is even evidence that GHK-Cu can reset pathological gene expression and help to recreate a state of health in dysfunctional systems[8].
GHK-Cu is found in high concentrations in the brain, though levels of the peptide decline with age. There is a thought, among scientists, that GHK-Cu may protect nervous system tissues against natural insults such as gene dysregulation and that it is the decline in GHK-Cu with age, and not the onset of new disease processes, that actually leads to neurodegeneration.
GHK-Cu Levels in various tissues
Source: PubMed
Research in rats indicates that one possible mechanism by which GHK-Cu protects brain tissue is by preventing apoptosis. This action appears to be mediated through the well-known miR-339-59/VEGFA pathway, which is active following brain bleeds and stroke. In the rat models, GHK-Cu improves neurological deficits in the brain, reduce swelling, and inhibited the death of neurons that is commonly bought about by overexpression of miR-339-5p[9].
Research in mice shows that GHK-Cu can protect the lungs against fibrosis that occurs following therapy with the cancer drug bleomycin[10]. This could pave the way for using GHK-Cu as a chemotherapy adjuvant that allows doses of these life-saving medications to be increased without risk of increased side effects. The study when a step farther, than usual, by identifying the likely pathway by which GHKC-Cu protects against fibrosis. It appears that the peptide regulations TNF-alpha dn IL-6 levels, both of which act as inflammatory molecules and affect the extracellular matrix and smooth muscle of the lung. By reducing inflammation in the lungs, GHK-Cu prevents fibrotic remodeling from taking place and improves collagen deposition.
Similar benefit of GHK-Cu in protecting lungs was found in mouse models of acute respiratory distress syndrome (ARDS), an inflammatory lung condition that can develop rapidly and be fatal. ARDS is associated with injury, infection, and certain drugs like those used in chemotherapy. Once again, GHK-Cu appeared to mediate its effects through decreased TNF-alpha and IL-6 expression[11].
In rat models, the administration of GHK-Cu had a dose-dependent effect on pain-induced behavior. The peptide appears to have analgesic effects that are produced through increased levels of the natural painkiller L-lysine[12]. Similar research has found that the peptide can also increase levels of L-arginine, another analgesic amino acid[13]. These findings open up new avenues for pain control that do not rely on addictive opiate medications or NSAIDs, which have been found to have negative effects on the heart.
GHK-Cu exhibits minimal side effects, low oral and excellent subcutaneous bioavailability in mice. Per kg dosage in mice does not scale to humans. GHK-Cu for sale at
The above literature was researched, edited and organized by Dr. Logan, M.D. Dr. Logan holds a doctorate degree from Case Western Reserve University School of Medicine and a B.S. in molecular biology.
Loren Pickart, Ph.D. has released 109 publications and is developing patents and analyzing GHK’s effects on human gene expression of 4,192 genes. In addition to GHK’s published potential uses on skin inflammation, metastatic cancer and COPD, it appears to have beneficial effects on other tissue systems such as the nervous system, gastrointestinal system, and mitochondrial system. His brief but detailed autobiography dives into the motivations and background behind his dedicating to skin, anti-aging, and life-long training.
Loren Pickart, Ph.D is being referenced as one of the leading scientists involved in the research and development of GHK-Cu. In no way is this doctor/scientist endorsing or advocating the purchase, sale, or use of this product for any reason. There is no affiliation or relationship, implied or otherwise, between
ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATONAL AND EDUCATIONAL PURPOSES ONLY.
The products offered on this website are furnished for in-vitro studies only. In-vitro studies (Latin: in glass) are performed outside of the body. These products are not medicines or drugs and have not been approved by the FDA to prevent, treat or cure any medical condition, ailment or disease. Bodily introduction of any kind into humans or animals is strictly forbidden by law.
PeptideGurus is a leading supplier of American-made research peptides, offering top-quality products at competitive prices. With a focus on excellence and customer service, they ensure a secure and convenient ordering process with global shipping.
© Copyright Peptide Gurus 2024. All rights reserved.
All products on this site are for Research, Development use only. Products are Not for Human consumption of any kind. The statements made within this website have not been evaluated by the US Food and Drug Administration or HEALTH CANADA. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease.
PeptideGurus is a chemical supplier. PeptideGurus is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. Peptide Sciences is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic act.
CONTACT
